Alberta Investment Management Corp (AIMCo)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,900
| Closed | -$262K | – | 920 |
|
|
2024
Q1 | $262K | Hold |
1,900
| – | – | ﹤0.01% | 937 |
|
|
2023
Q4 | $250K | Hold |
1,900
| – | – | ﹤0.01% | 938 |
|
|
2023
Q3 | $214K | Sell |
1,900
-80,895
| -98% | -$9.1M | ﹤0.01% | 970 |
|
|
2023
Q2 | $7.81M | Buy |
82,795
+7,777
| +10% | +$733K | 0.08% | 238 |
|
|
2023
Q1 | $7.59M | Sell |
75,018
-4,391
| -6% | -$444K | 0.07% | 253 |
|
|
2022
Q4 | $9.48M | Sell |
79,409
-19,697
| -20% | -$2.35M | 0.08% | 264 |
|
|
2022
Q3 | $10.5M | Buy |
99,106
+67,244
| +211% | +$7.14M | 0.08% | 263 |
|
|
2022
Q2 | $3.11M | Buy |
31,862
+162
| +0.5% | +$15.8K | 0.02% | 612 |
|
|
2022
Q1 | $2.97M | Buy |
+31,700
| New | +$2.97M | 0.02% | 684 |
|
|
2017
Q1 | – | Sell |
-52,245
| Closed | -$2.02M | – | 870 |
|
|
2016
Q4 | $2.02M | Buy |
52,245
+1,370
| +3% | +$53K | 0.02% | 459 |
|
|
2016
Q3 | $2.58M | Buy |
50,875
+640
| +1% | +$32.4K | 0.03% | 393 |
|
|
2016
Q2 | $2.28M | Hold |
50,235
| – | – | 0.03% | 395 |
|
|
2016
Q1 | $1.99M | Sell |
50,235
-100,722
| -67% | -$3.98M | 0.03% | 382 |
|
|
2015
Q4 | $8.54M | Sell |
150,957
-7,050
| -4% | -$399K | 0.1% | 245 |
|
|
2015
Q3 | $6.29M | Sell |
158,007
-15,507
| -9% | -$617K | 0.07% | 303 |
|
|
2015
Q2 | $8.29M | Sell |
173,514
-226,363
| -57% | -$10.8M | 0.09% | 282 |
|
|
2015
Q1 | $15.9M | Buy |
+399,877
| New | +$15.9M | 0.17% | 156 |
|